5I0.SI - QT Vascular Ltd.

SES - SES Delayed Price. Currency in SGD
0.012
+0.001 (+9.091%)
As of 10:04AM SGT. Market open.
Stock chart is not supported by your current browser
Previous Close0.011
Open0.012
Bid0.011 x 0
Ask0.012 x 0
Day's Range0.011 - 0.012
52 Week Range0.006 - 0.115
Volume570,300
Avg. Volume25,278,281
Market Cap20.8M
Beta-1.12
PE Ratio (TTM)-0.39
EPS (TTM)-0.03
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire5 months ago

    QT Vascular Enters Into Asset Purchase Option Agreement With Medtronic

    SINGAPORE, May 12, 2017 /PRNewswire/ -- QT Vascular Ltd., (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced today that it has entered into an asset purchase option agreement ("Option Agreement") with Medtronic, for the acquisition of the Group's non-drug coated Chocolate® PTA.

  • PR Newswire5 months ago

    QT Vascular Enters Into Asset Purchase Option Agreement With Medtronic

    SINGAPORE, May 12, 2017 /PRNewswire/ -- QT Vascular Ltd., (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced today that it has entered into an asset purchase option agreement ("Option Agreement") with Medtronic, for the acquisition of the Group's non-drug coated Chocolate® PTA. "We are excited that Medtronic, the world's leading medical device company has taken an interest in our non-drug coated peripheral products," stated Eitan Konstantino, PhD, CEO of QT Vascular.

  • PR Newswire7 months ago

    QT Vascular Secures Up To S$20 million Capital Commitment From GEM Global

    SINGAPORE, March 21, 2017 /PRNewswire/ -- QT Vascular Ltd., (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group") announced that it has signed an agreement ("Agreement") with GEM Global Yield Fund LLC SCS ("GEM Global"), the New York based private alternative investment group, which has agreed to provide the Company with up to S$10 million over the next 30 months. The Company, at its absolute discretion, can opt for an additional S$10 million commitment on terms (including quantum) identical to this Agreement with a period of six months from the date of this Agreement with GEM Global. The Company will use the funds to significantly strengthen the business.

  • PR Newswire8 months ago

    QT Vascular Signs Agreement With Medtronic For Distribution Of Chocolate® PTA Catheter

    SINGAPORE, Feb. 2, 2017 /PRNewswire/ -- QT Vascular Ltd., (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced today that it has signed a definitive agreement ("Agreement") with Medtronic, Inc. ("Medtronic") for the worldwide distribution of its Chocolate® PTA catheter for a period of five years and automatically renewable for two additional one-year periods. Chocolate® represents a breakthrough in PTA design.

  • PR Newswire10 months ago

    FDA Grants QT Vascular Full IDE Approval to Begin Pivotal Trial Of Its Drug-Coated Balloon, Chocolate Touch™

    SINGAPORE, Dec. 16, 2016 /PRNewswire/ -- QT Vascular Ltd., (the " Company " or " QT Vascular ", and together with its subsidiaries, the " Group "), is a global company engaged ...

  • PR Newswire11 months ago

    QT Vascular Announces That The Federal Circuit Denies AngioScore Petition For Rehearing

    SINGAPORE, Nov. 18, 2016 /PRNewswire/ --  QT Vascular Ltd. (the " Company " or " QT Vascular ", and together with its subsidiaries, the " Group "), is a global company engaged ...